Board of Scientific Counselors, Deputy Director for Infectious Diseases, 73020 [2023-23460]

Download as PDF 73020 Federal Register / Vol. 88, No. 204 / Tuesday, October 24, 2023 / Notices announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–23458 Filed 10–23–23; 8:45 am] [FR Doc. 2023–23459 Filed 10–23–23; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Board of Scientific Counselors, Deputy Director for Infectious Diseases ddrumheller on DSK120RN23PROD with NOTICES1 Notice of Closed Meeting Pursuant to 5 U.S.C section 1009(d), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended, and the Determination of the Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— CE24–034, Rigorous Evaluation of Policies for their Impacts on the Primary Prevention of Multiple Forms of Violence. Date: February 27, 2024. Time: 8 a.m.–5 p.m., EST. Place: Web Conference. Agenda: To review and evaluate grant applications. For Further Information Contact: Carlisha Gentles, PharmD, BCPS, CDCES, Scientific Review Officer, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone: (770)488–1504; Email: CGentles@cdc.gov. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other VerDate Sep<11>2014 17:08 Oct 23, 2023 Jkt 262001 Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Board of Scientific Counselors, Deputy Director for Infectious Diseases (BSC, DDID). This virtual meeting is open to the public via Zoom, limited only by the number of web conference lines available (500 lines). Registration in advance is required by accessing the link below in the addresses section. Time will be available for public comment. SUMMARY: The meeting will be held on November 30, 2023, from 1:30 p.m. to 3 p.m., EST. ADDRESSES: Zoom virtual meeting. Registration in advance is required by accessing the link at https:// cdc.zoomgov.com/webinar/register/WN_ _r2EU3xBTB6MBiQq_HdqNQ. Instructions to access the meeting will be provided following registration. FOR FURTHER INFORMATION CONTACT: Sarah Wiley, MPH, Senior Advisor, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H16–5, Atlanta, Georgia 30329–4037. Telephone: (404) 639–4840; Email: SWiley@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Board of Scientific Counselors, Deputy Director for Infectious Diseases (BSC, DDID) provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, Centers for Disease Control and Prevention (CDC); and the Directors DATES: PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 of the National Center for Emerging and Zoonotic Infectious Diseases, the National Center for HIV, Viral Hepatitis, STD, and TB Prevention, the National Center for Immunization and Respiratory Diseases, concerning strategies, goals, and priorities for the programs and research within the national centers and monitors the overall strategic direction and focus of CDC’s infectious disease programs and centers. Matters To Be Considered: The agenda will include updates and discussions on recent outbreaks and disease surveillance strategies, as well as a brief report from one of the Board’s workgroups: the Food Safety Modernization Act Surveillance Working Group. Agenda items are subject to change as priorities dictate. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–23460 Filed 10–23–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 5 U.S.C. Section1009(d), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\24OCN1.SGM 24OCN1

Agencies

[Federal Register Volume 88, Number 204 (Tuesday, October 24, 2023)]
[Notices]
[Page 73020]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23460]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Deputy Director for Infectious 
Diseases

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC) announces the following meeting of 
the Board of Scientific Counselors, Deputy Director for Infectious 
Diseases (BSC, DDID). This virtual meeting is open to the public via 
Zoom, limited only by the number of web conference lines available (500 
lines). Registration in advance is required by accessing the link below 
in the addresses section. Time will be available for public comment.

DATES: The meeting will be held on November 30, 2023, from 1:30 p.m. to 
3 p.m., EST.

ADDRESSES: Zoom virtual meeting. Registration in advance is required by 
accessing the link at https://cdc.zoomgov.com/webinar/register/WN__r2EU3xBTB6MBiQq_HdqNQ. Instructions to access the meeting will be 
provided following registration.

FOR FURTHER INFORMATION CONTACT: Sarah Wiley, MPH, Senior Advisor, 
National Center for Emerging and Zoonotic Infectious Diseases, Centers 
for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H16-
5, Atlanta, Georgia 30329-4037. Telephone: (404) 639-4840; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Purpose: The Board of Scientific Counselors, 
Deputy Director for Infectious Diseases (BSC, DDID) provides advice and 
guidance to the Secretary, Department of Health and Human Services; the 
Director, Centers for Disease Control and Prevention (CDC); and the 
Directors of the National Center for Emerging and Zoonotic Infectious 
Diseases, the National Center for HIV, Viral Hepatitis, STD, and TB 
Prevention, the National Center for Immunization and Respiratory 
Diseases, concerning strategies, goals, and priorities for the programs 
and research within the national centers and monitors the overall 
strategic direction and focus of CDC's infectious disease programs and 
centers.
    Matters To Be Considered: The agenda will include updates and 
discussions on recent outbreaks and disease surveillance strategies, as 
well as a brief report from one of the Board's workgroups: the Food 
Safety Modernization Act Surveillance Working Group. Agenda items are 
subject to change as priorities dictate.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-23460 Filed 10-23-23; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.